MeSH note : elicits a weak antibody & T-cell response in some people; no longer undergoing trials
as an Aids Vaccine; studies are underway to examine HIVAC-1e in vaccinia-naive persons;
recombinant vaccine using a vaccinia vector & gp160; coordinate with HIV envelope
protein gp160(NM);